Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.
The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.
Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.
In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.
Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.
The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.
Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.
Align Technology has received CE Mark in Europe and MHRA registration in the UK for its Invisalign® Palatal Expander System. This innovative 3D-printed device offers a removable alternative to traditional palatal expanders for treating narrow maxilla in patients with primary, mixed, or permanent dentition. Combined with Invisalign First™ aligners, it provides doctors with a complete early intervention treatment solution for both skeletal and dental arch expansion. The system is approved for broad patient applicability, including growing children, teens, and adults. The product is expected to be commercially available across EMEA in Q1 2025.
Align Technology hosted its 2024 Invisalign Ortho Summit, a premier educational event focused on digital practice transformation and treatment experiences. The three-day summit attracted over 1,000 doctors and practice team members who participated in hands-on experiences, clinical training, and practice growth strategies. The event showcased the Align Digital Platform and innovations including the Invisalign System with mandibular advancement, Invisalign Palatal Expander System, and Invisalign First. The Innovation Hub demonstrated digital tools and resources, while breakout sessions covered topics from clinical best practices to patient experience optimization.
Align Technology has launched its 2025 Annual Research Award Program, offering up to $300,000 in funding for university faculty conducting dental and orthodontic research globally. The program, which has funded approximately $3.75 million in research since 2010, will distribute twelve one-year awards of up to $25,000 each across Americas, EMEA, and APAC regions. Full-time and part-time faculty at universities where Invisalign® treatment or iTero™ scanner is available can apply until March 7, 2025, with winners announced by June 2, 2025.
Align Technology (ALGN) has announced its participation in four upcoming financial conferences in November and December 2024. The company will present at the UBS Global Healthcare Conference in Rancho Palos Verdes, the Jefferies London Healthcare Conference in England, the Piper Sandler Healthcare Conference in New York, and the Evercore HealthCONx Conference in Coral Gables. CFO John Morici will attend all events, with CEO Joseph Hogan joining for the London conference.
All presentations will be accessible via webcast through Align's Investor Relations website, with recordings available for approximately three months afterward. Align Technology is known for its Invisalign System, iTero intraoral scanners, and exocad CAD/CAM software, serving over 271,000 doctors globally.
Align Technology (ALGN) has announced plans to repurchase $275 million of its common stock through open market repurchases under its $1.0 billion stock repurchase program approved in January 2023. The repurchases will be executed via a Rule 10b5-1 trading plan and are expected to complete by January 2025, funded by cash on hand. As of September 30, 2024, Align had approximately 74.8 million shares outstanding and $1,041.9 million in cash and cash equivalents. The company cites strong balance sheet and cash flow generation as drivers for this decision.
Align Technology (ALGN) announced Frank Quinn will rejoin as Executive Vice President and Managing Director of the Americas region, reporting to CEO Joe Hogan. This appointment comes as part of a global organizational restructuring, which eliminates the position of Raj Pudipeddi, who will leave in Q4 2024. Quinn returns to Align after serving as Chief Revenue Officer at LightForce Orthodontics. During his previous 9-year tenure at Align, he held various leadership positions including VP and General Manager of the United States. Quinn brings extensive experience in orthodontics industry growth, strategy, and revenue management.
Align Technology (ALGN) reported Q3'24 total revenues of $977.9 million, up 1.8% year-over-year but down 4.9% sequentially. Clear Aligner revenues decreased 1.0% year-over-year to $786.8 million, while Imaging Systems and CAD/CAM Services revenues grew 15.6% to $191.0 million. The company achieved a GAAP operating margin of 16.6% and non-GAAP operating margin of 22.1%. Q3'24 net income was $116.0 million ($1.55 per diluted share). The company announced plans to repurchase up to $275.0 million of common stock starting Q4'24 and implemented a global restructuring plan with expected charges of approximately $30 million.
Align Technology (NASDAQ: ALGN) has announced the release of an enhanced version of Invisalign Smile Architect software with Multiple Treatment Plans functionality. This innovation allows doctors to compare orthodontic-only and ortho-restorative treatment plans side-by-side within the ClinCheck® treatment planning software. The software integrates with the Align Digital Platform and enables doctors to demonstrate treatment simulations using iTero scanners during office visits. The new feature includes tools like facial lines, tooth mass analysis, and in-face visualizations. The software is expected to be available to Invisalign trained doctors in Q4 2024.
Align Technology (NASDAQ: ALGN) has announced new iTero intraoral scanner innovations aimed at enhancing digital dentistry workflows. The company introduced three key products: the Align Oral Health Suite with comparison tools for assessments and reports, Invisalign Outcome Simulator Pro with multiple treatment simulations, and iTero Design Suite for in-practice 3D printing. GP practices using iTero scanners and Align Oral Health Suite saw 9% higher estimated monthly revenue compared to non-users. These innovations support patient education, treatment planning, and practice efficiency, and are expected to be available in Q4 2024.
Align Technology (Nasdaq: ALGN) has announced the availability of its Invisalign Palatal Expander System in Singapore. This innovative, removable device is designed for skeletal and dental expansion in growing patients, offering an alternative to traditional metal expanders. The system, now listed on the Singapore Medical Device Register as a class B medical device, is 3D printed and customized based on iTero intraoral scans.
Combined with Invisalign First aligners, it provides a complete early intervention treatment solution for Phase 1 orthodontic treatment. The system is already available in Australia, New Zealand, and Hong Kong, with plans to expand to other APAC markets in 2024. This launch reflects Align's commitment to advancing digital orthodontics and enhancing patient treatment experiences.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
What is Align Technology's main product?
How many patients have been treated with Invisalign?
What technologies does Align Technology offer?
What is the iTero Lumina™ scanner?
What was the purpose of acquiring Cubicure GmbH?
How does Align Technology support scientific research?
What is the Align Digital Platform?
How many Invisalign-trained doctors are there globally?
What is the financial outlook for Align Technology?
Where can I find more information about Align Technology’s products?
